Nivolumab Shows Sustained 9-Year Survival Benefit in Resected Stage III/IV Melanoma
Nivolumab, a PD-1 checkpoint inhibitor, demonstrates remarkable durability in advanced melanoma patients with survival benefits persisting nearly a decade post…
Found 1465 results for "cancer"
Nivolumab, a PD-1 checkpoint inhibitor, demonstrates remarkable durability in advanced melanoma patients with survival benefits persisting nearly a decade post…
Scientists have engineered circular RNA structures that form self-looping configurations, demonstrating enhanced stability and prolonged therapeutic activity c…
Recent trial data indicates that biparametric MRI (bpMRI), which uses only two imaging sequences instead of the standard three or more, demonstrates equivalent…
The PRIME trial found that biparametric MRI (bpMRI) performs equivalently to the standard multiparametric MRI (mpMRI) for detecting clinically significant pros…
The PRIME clinical trial establishes that biparametric MRI (bpMRI) achieves equivalent diagnostic performance to multiparametric MRI (mpMRI) for identifying cl…
Breast, colorectal, lung, brain, and lymphoid cancers account for approximately 70% of cancer deaths in Americans under 50, with colorectal cancer showing part…
Ten patients with severe, treatment-resistant autoimmune conditions—five with antisynthetase syndrome and five with systemic sclerosis—experienced significant…
A population-based screening trial involving over 270,000 Swedish adults demonstrated that both colonoscopy and fecal immunochemical testing (FIT) significantl…
Age-related mutations in blood stem cells, termed clonal hematopoiesis of indeterminate potential (CHIP), appear to amplify the therapeutic benefits of PD-1 an…
Mammary gland involution following weaning triggers widespread cellular senescence that orchestrates tissue remodeling but simultaneously creates microenvironm…
A comprehensive WHO analysis examining 30 modifiable risk factors reveals that 40% of global cancer cases stem from preventable causes, representing the most e…
Biophysical measurements reveal that metastatic cancer cells undergo measurable changes in internal viscosity that correlate with their ability to detach from…
An international randomized controlled trial demonstrated that structured exercise programs significantly improved both disease-free and overall survival rates…
Cancer incidence is surging across Sub-Saharan Africa, with the region accounting for the majority of new cases in low-income countries globally. This analysis…
Dendritic cells expressing the transcription factor Etv3 demonstrate enhanced capacity to promote immune tolerance rather than inflammatory responses. This mol…
Cancer immunotherapy drugs targeting the PD-1 checkpoint protein significantly reduced latent HIV reservoirs in co-infected patients, according to transcriptom…
Blocking the PD-1 immune checkpoint protein triggers interferon-driven antiviral responses that measurably reduce latent HIV reservoirs in cancer patients alre…
Age-related mutations in blood stem cells, known as clonal hematopoiesis of indeterminate potential (CHIP), appear to improve patient responses to immune check…
Researchers compiled 748,679 single cells from multiple acute myeloid leukemia studies to map how age influences gene expression patterns in t(8;21) AML, a sub…
Marcel Deckert's team at INSERM in Nice has identified USP9X as a critical vulnerability in melanoma's adaptive machinery. This deubiquitinating enzyme stabili…